Point72 Hong Kong LTD Acadia Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

  • $1.73 Billion
  • Q3 2025

A detailed history of Point72 Hong Kong LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Point72 Hong Kong LTD holds 33,715 shares of ACAD stock, worth $809,834. This represents 0.04% of its overall portfolio holdings.

Number of Shares
33,715
Previous 53,946 37.5%
Holding current value
$809,834
Previous $1.16 Million 38.18%
% of portfolio
0.04%
Previous 0.09%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$20.88 - $26.57 $422,423 - $537,537
-20,231 Reduced 37.5%
33,715 $719,000
Q2 2025

Aug 14, 2025
BUY
$14.1 - $22.95 $368,771 - $600,234
26,154 Added 94.11%
53,946 $1.16 Million
Q1 2025

May 15, 2025
BUY
$16.61 - $20.29 $62,088 - $75,844
3,738 Added 15.54%
27,792 $461,000
Q4 2024

Feb 14, 2025
BUY
$14.29 - $18.76 $343,731 - $451,253
24,054 New
24,054 $441,000
Q1 2024

May 15, 2024
BUY
$17.79 - $30.86 $296,612 - $514,528
16,673 Added 146.5%
28,054 $518,000
Q4 2023

Feb 14, 2024
BUY
$20.78 - $31.77 $236,497 - $361,574
11,381 New
11,381 $356,000
Q2 2022

Aug 15, 2022
BUY
$13.01 - $27.22 $218,698 - $457,568
16,810 Added 280.03%
22,813 $321,000
Q1 2022

May 16, 2022
BUY
$20.94 - $27.5 $109,264 - $143,495
5,218 Added 664.71%
6,003 $145,000
Q4 2021

Feb 14, 2022
SELL
$16.79 - $27.09 $116,891 - $188,600
-6,962 Reduced 89.87%
785 $18,000
Q3 2021

Nov 15, 2021
SELL
$15.78 - $24.77 $27,472 - $43,124
-1,741 Reduced 18.35%
7,747 $129,000
Q2 2021

Aug 16, 2021
BUY
$19.4 - $27.42 $28,226 - $39,896
1,455 Added 18.11%
9,488 $231,000
Q1 2021

May 17, 2021
BUY
$25.02 - $54.99 $200,985 - $441,734
8,033 New
8,033 $207,000
Q3 2020

Nov 16, 2020
SELL
$36.42 - $57.0 $474,406 - $742,482
-13,026 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$39.26 - $52.73 $511,400 - $686,860
13,026 New
13,026 $631,000
Q1 2020

May 15, 2020
SELL
$31.65 - $46.87 $9,336 - $13,826
-295 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$36.21 - $51.4 $10,681 - $15,163
295 New
295 $13,000
Q3 2018

Nov 14, 2018
SELL
$13.03 - $21.81 $46,790 - $78,319
-3,591 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$15.07 - $22.34 $12,779 - $18,944
-848 Reduced 19.1%
3,591 $55,000
Q1 2018

May 15, 2018
BUY
$22.47 - $32.33 $88,936 - $127,962
3,958 Added 822.87%
4,439 $100,000
Q4 2017

Feb 14, 2018
BUY
$26.84 - $39.14 $11,568 - $16,869
431 Added 862.0%
481 $14,000
Q3 2017

Nov 14, 2017
BUY
$29.49 - $38.37 $1,474 - $1,918
50
50 $2,000

Others Institutions Holding ACAD

# of Institutions
373
Shares Held
162M
Call Options Held
1.46M
Put Options Held
1.09M
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $3.89B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email